← Open Payments lookup

NICHOLAS GAGHEN: Open Payments

NPI 1861105561 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,213 in 47 payments from 11 companies in 2025. Trend: 2023 $428 · 2024 $1,083 · 2025 $1,213

Food & beverage: $1,213
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation10$196
Boehringer Ingelheim Pharmaceuticals, Inc.6$180
Alnylam Pharmaceuticals Inc.4$169
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)3$153
Amgen Inc.8$132
Boston Scientific Corporation2$127
PFIZER INC.6$106
AstraZeneca Pharmaceuticals LP3$49
E.R. Squibb & Sons, L.L.C.2$41
Bayer Healthcare Pharmaceuticals Inc.2$37

Products named: JARDIANCE, LEQVIO, AMVUTTRA, LifeVest, REPATHA, ENROUTE Transcarotid Neuroprotection System, ELIQUIS, VYNDAQEL.

Industry payments across AL — which companies pay providers there.